Email or username:

Password:

Forgot your password?
Top-level
DThoris

@almad @rbreich Given Moderna's profits, I'd say they made back the money they spent. If they hadn't, it wouldn't be profit, it'd be covering cost.

3 comments
Almad

@DejahEntendu @rbreich I am not sure this is how R&D accounting works, hence asking about data

(I am the first one to agree on greediness as that’s kinda the point of public companies, but I also like primary sources and like to know proportions)

DThoris

@almad @rbreich that's the thing. They don't release R&D figs, to my knowledge. It's not like they developed the mRNA tech. That already existed. Yes, creating a vaccine isn't overltly simple or necessarily cheap, but they do it every year for flu, and the costs for flu vaccine is closer to what was being charged last year, not what they're proposing now.

Almad

@DejahEntendu @rbreich AFAIK the expensive part of vaccines are trials, and those are mostly expensive because of waiting for sufficient amount of people to get infected.

Which I assume is not mandated for flu vaccine since that’s just remix, and was easy-ish and subsidized for Covid during pandemic

Go Up